Kurzrock R - Search Results

1

Identification of targets for prostate cancer immunotherapy.

Papanicolau-Sengos A, Yang Y, Pabla S, Lenzo FL, Kato S, Kurzrock R, DePietro P, Nesline M, Conroy J, Glenn S, Chatta G, Morrison C. Papanicolau-Sengos A, et al. Among authors: kurzrock r. Prostate. 2019 Apr;79(5):498-505. doi: 10.1002/pros.23756. Epub 2019 Jan 6. Prostate. 2019. PMID: 30614027

2

Cyclin-dependent kinase pathway aberrations in diverse malignancies: clinical and molecular characteristics.

Kato S, Schwaederle M, Daniels GA, Piccioni D, Kesari S, Bazhenova L, Shimabukuro K, Parker BA, Fanta P, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Cell Cycle. 2015;14(8):1252-9. doi: 10.1080/15384101.2015.1014149. Cell Cycle. 2015. PMID: 25695927 Free PMC article.

3

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.

Patel SP, Kurzrock R. Patel SP, et al. Among authors: kurzrock r. Mol Cancer Ther. 2015 Apr;14(4):847-56. doi: 10.1158/1535-7163.MCT-14-0983. Epub 2015 Feb 18. Mol Cancer Ther. 2015. PMID: 25695955 Review.

4

Molecular landscape of prostate cancer: implications for current clinical trials.

Khemlina G, Ikeda S, Kurzrock R. Khemlina G, et al. Among authors: kurzrock r. Cancer Treat Rev. 2015 Nov;41(9):761-6. doi: 10.1016/j.ctrv.2015.07.001. Epub 2015 Jul 9. Cancer Treat Rev. 2015. PMID: 26210103 Free article. Review.

5

Challenges and perspective of drug repurposing strategies in early phase clinical trials.

Kato S, Moulder SL, Ueno NT, Wheler JJ, Meric-Bernstam F, Kurzrock R, Janku F. Kato S, et al. Among authors: kurzrock r. Oncoscience. 2015 Jun 30;2(6):576-80. doi: 10.18632/oncoscience.173. eCollection 2015. Oncoscience. 2015. PMID: 26244164 Free PMC article.

6

Genomic landscape of salivary gland tumors.

Kato S, Elkin SK, Schwaederle M, Tomson BN, Helsten T, Carter JL, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Oncotarget. 2015 Sep 22;6(28):25631-45. doi: 10.18632/oncotarget.4554. Oncotarget. 2015. PMID: 26247885 Free PMC article.

7

The Conundrum of Genetic "Drivers" in Benign Conditions.

Kato S, Lippman SM, Flaherty KT, Kurzrock R. Kato S, et al. Among authors: kurzrock r. J Natl Cancer Inst. 2016 Apr 7;108(8):djw036. doi: 10.1093/jnci/djw036. Print 2016 Aug. J Natl Cancer Inst. 2016. PMID: 27059373 Free PMC article. Review.

8

Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics.

Helsten T, Kato S, Schwaederle M, Tomson BN, Buys TP, Elkin SK, Carter JL, Kurzrock R. Helsten T, et al. Among authors: kurzrock r. Mol Cancer Ther. 2016 Jul;15(7):1682-90. doi: 10.1158/1535-7163.MCT-16-0071. Epub 2016 May 11. Mol Cancer Ther. 2016. PMID: 27196769

9

Genomic Landscape of Malignant Mesotheliomas.

Kato S, Tomson BN, Buys TP, Elkin SK, Carter JL, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Mol Cancer Ther. 2016 Oct;15(10):2498-2507. doi: 10.1158/1535-7163.MCT-16-0229. Epub 2016 Aug 9. Mol Cancer Ther. 2016. PMID: 27507853

10

RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.

Kato S, Subbiah V, Marchlik E, Elkin SK, Carter JL, Kurzrock R. Kato S, et al. Among authors: kurzrock r. Clin Cancer Res. 2017 Apr 15;23(8):1988-1997. doi: 10.1158/1078-0432.CCR-16-1679. Epub 2016 Sep 28. Clin Cancer Res. 2017. PMID: 27683183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,016 results

Search Page

Filters